Palumbo Wealth Management LLC Heron Therapeutics, Inc. Transaction History
Palumbo Wealth Management LLC
- $289 Million
- Q1 2025
A detailed history of Palumbo Wealth Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 124,103 shares of HRTX stock, worth $289,159. This represents 0.09% of its overall portfolio holdings.
Number of Shares
124,103Holding current value
$289,159% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
175Shares Held
115MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$62.2 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$19.8 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$19 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$16.3 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $277M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...